Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
PLoS One ; 8(12): e83564, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-24376718

RESUMO

N-acylhomoserine lactone (AHL)-mediated quorum-sensing (QS) regulates virulence functions in plant and animal pathogens such as Agrobacterium tumefaciens and Pseudomonas aeruginosa. A chemolibrary of more than 3500 compounds was screened using two bacterial AHL-biosensors to identify QS-inhibitors (QSIs). The purity and structure of 15 QSIs selected through this screening were verified using HPLC MS/MS tools and their activity tested on the A. tumefaciens and P. aeruginosa bacterial models. The IC50 value of the identified QSIs ranged from 2.5 to 90 µg/ml, values that are in the same range as those reported for the previously identified QSI 4-nitropyridine-N-oxide (IC50 24 µg/ml). Under the tested culture conditions, most of the identified QSIs did not exhibit bacteriostatic or bactericidal activities. One third of the tested QSIs, including the plant compound hordenine and the human sexual hormone estrone, decreased the frequency of the QS-regulated horizontal transfer of the tumor-inducing (Ti) plasmid in A. tumefaciens. Hordenine, estrone as well as its structural relatives estriol and estradiol, also decreased AHL accumulation and the expression of six QS-regulated genes (lasI, lasR, lasB, rhlI, rhlR, and rhlA) in cultures of the opportunist pathogen P. aeruginosa. Moreover, the ectopic expression of the AHL-receptors RhlR and LasR of P. aeruginosa in E. coli showed that their gene-regulatory activity was affected by the QSIs. Finally, modeling of the structural interactions between the human hormones and AHL-receptors LasR of P. aeruginosa and TraR of A. tumefaciens confirmed the competitive binding capability of the human sexual hormones. This work indicates potential interferences between bacterial and eukaryotic hormonal communications.


Assuntos
Hormônios Esteroides Gonadais/farmacologia , Percepção de Quorum/efeitos dos fármacos , Agrobacterium tumefaciens/citologia , Agrobacterium tumefaciens/efeitos dos fármacos , Agrobacterium tumefaciens/genética , Proteínas de Bactérias/química , Proteínas de Bactérias/genética , Proteínas de Bactérias/metabolismo , Relação Dose-Resposta a Droga , Avaliação Pré-Clínica de Medicamentos , Transferência Genética Horizontal/efeitos dos fármacos , Hormônios Esteroides Gonadais/química , Hormônios Esteroides Gonadais/metabolismo , Humanos , Indóis/química , Indóis/farmacologia , Concentração Inibidora 50 , Modelos Moleculares , Plasmídeos/genética , Conformação Proteica , Pseudomonas aeruginosa/citologia , Pseudomonas aeruginosa/efeitos dos fármacos , Tiramina/análogos & derivados , Tiramina/farmacologia
2.
Eur J Neurosci ; 32(12): 2096-104, 2010 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-21143664

RESUMO

Steroid hormones of gonadal origin act on the neonatal brain, particularly the hypothalamus, to produce sex differences that underlie copulatory behavior. Neuroanatomical sex differences include regional volume, cell number, connectivity, morphology, physiology, neurotransmitter phenotype and molecular signaling, all of which are determined by the action of steroid hormones, particularly by estradiol in males, and are established by diverse downstream effects. Sex differences in distinct hypothalamic regions can be organized by the same steroid hormone, but the direction of a sex difference is often specific to one region or cell type, illustrating the wide range of effects that steroid hormones have on the developing brain. Substantial progress has been made in elucidating the downstream mechanisms through which gonadal hormones sexually differentiate the brain, but gaps remain in establishing the precise relationship between changes in neuronal morphology and behavior. A complete understanding of sexual differentiation will require integrating the diverse mechanisms across multiple brain regions into a functional network that regulates behavioral output.


Assuntos
Hormônios Esteroides Gonadais/metabolismo , Hipotálamo/crescimento & desenvolvimento , Comportamento Sexual Animal/fisiologia , Animais , Encéfalo/anatomia & histologia , Encéfalo/fisiologia , Feminino , Hormônios Esteroides Gonadais/química , Hipotálamo/metabolismo , Masculino , Caracteres Sexuais , Diferenciação Sexual/fisiologia
3.
Proc Natl Acad Sci U S A ; 107(31): 13942-7, 2010 Aug 03.
Artigo em Inglês | MEDLINE | ID: mdl-20643930

RESUMO

Corticosteroid hormones are critical for controlling metabolism, hydromineral balance, and the stress response in vertebrates. Although corticosteroid hormones have been well characterized in most vertebrate groups, the identity of the earliest vertebrate corticosteroid hormone has remained elusive. Here we provide evidence that 11-deoxycortisol is the corticosteroid hormone in the lamprey, a member of the agnathans that evolved more than 500 million years ago. We used RIA, HPLC, and mass spectrometry analysis to determine that 11-deoxycortisol is the active corticosteroid present in lamprey plasma. We also characterized an 11-deoxycortisol receptor extracted from sea lamprey gill cytosol. The receptor was highly specific for 11-deoxycortisol and exhibited corticosteroid binding characteristics, including DNA binding. Furthermore, we observed that 11-deoxycortisol was regulated by the hypothalamus-pituitary axis and responded to acute stress. 11-deoxycortisol implants reduced sex steroid concentrations and up-regulated gill Na+, K+-ATPase, an enzyme critical for ion balance. We show here that 11-deoxycortisol functioned as both a glucocorticoid and a mineralocorticoid in the lamprey. Our findings indicate that a complex and highly specific corticosteroid signaling pathway evolved at least 500 million years ago with the arrival of the earliest vertebrate.


Assuntos
Cortodoxona/metabolismo , Lampreias/metabolismo , Animais , Cortodoxona/química , Hormônios Esteroides Gonadais/química , Hormônios Esteroides Gonadais/metabolismo , Hipotálamo/metabolismo , Ferro/metabolismo , Estrutura Molecular , Hipófise/metabolismo , Receptores de Glucocorticoides/metabolismo , ATPase Trocadora de Sódio-Potássio/metabolismo
4.
Biosci Biotechnol Biochem ; 71(9): 2325-8, 2007 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-17827674

RESUMO

In the course of screening for 17alpha-hydroxylase/C17,20-lyase inhibitors from food ingredients, the methanol soluble fraction of green tea and black tea, which were expected to be rich in catechin and theaflavin content, showed potent inhibitory activity. (-)-Epigallocathechin gallate and theaflavin 3-O-gallate with a pirogallol moiety significantly inhibited C17,20-lyase activity on IC50 values of 24.5 microM and 11.5 microM respectively. They had potent cytotoxicity against human prostate cancer LNCaP cells (IC50=28.1 microM and 37.4 microM).


Assuntos
Biflavonoides/farmacologia , Catequina/farmacologia , Inibidores Enzimáticos/farmacologia , Esteroide 17-alfa-Hidroxilase/metabolismo , Chá/química , Testículo/efeitos dos fármacos , Testículo/enzimologia , Animais , Cor , Inibidores Enzimáticos/química , Hormônios Esteroides Gonadais/biossíntese , Hormônios Esteroides Gonadais/química , Concentração Inibidora 50 , Masculino , Estrutura Molecular , Ratos , Relação Estrutura-Atividade
5.
Expert Opin Investig Drugs ; 12(6): 1017-25, 2003 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12783605

RESUMO

Deficiency of the weak androgen dehydroepiandrosterone (DHEA) and its sulfoconjugated metabolite DHEA-S has been associated with a number of serious illnesses, including lupus, diabetes, Alzheimer's disease and some cancers. Accordingly, supplementation with DHEA has been proposed for a variety of illnesses. Observational clinical studies and in vitro experiments have suggested that DHEA treatment might have a significant impact on immunological function, bone density, cognition, atherosclerotic disease, some malignancies, insulin resistance and obesity. Endogenous circulating DHEA levels, however, may vary widely by gender, age and ethnicity and can be affected by acute changes in corticosteroid production, alcohol intake, smoking, body mass index, medications and thyroid function [1-3]. Clearly, these variables complicate the interpretation of clinical data. DHEA also gives rise to a number of as yet poorly characterised metabolites, further confusing the assessment of its net effects when considered as treatment in heterogenous populations. Given the complexity of potential effects of DHEA and its metabolites, coupled to the diversity of clinical conditions that they might, at least in theory, affect, it is not surprising that clinical confirmation of efficacy in several clinical contexts has been inconsistent and controversial, hampering drug development in what might potentially be an important and widespread market. The current review will consider recent work suggesting efficacy of DHEA (GL-701, prasterone, Prestara( trade mark ) [US], Anastar( trade mark ) [Europe]; Genelabs) in systemic lupus erythematosus.


Assuntos
Desidroepiandrosterona/uso terapêutico , Drogas em Investigação/uso terapêutico , Hormônios Esteroides Gonadais/uso terapêutico , Lúpus Eritematoso Sistêmico/tratamento farmacológico , Androgênios/química , Androgênios/metabolismo , Androgênios/uso terapêutico , Animais , Desidroepiandrosterona/química , Desidroepiandrosterona/metabolismo , Drogas em Investigação/química , Drogas em Investigação/metabolismo , Hormônios Esteroides Gonadais/química , Hormônios Esteroides Gonadais/metabolismo , Humanos , Lúpus Eritematoso Sistêmico/metabolismo
6.
Eur J Pharm Biopharm ; 54(2): 229-33, 2002 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-12191696

RESUMO

Among the different methods used to increase the aqueous drug solubility, the preparation of a solid dispersion with a soluble carrier represents an interesting formulative approach. We substituted polyvinylalcohol with triethyleneglycolmonoethylether and obtained a suitable material for the formulation of a solid dispersion of progesterone, by spray-drying. In particular, we evaluated the influence of the polyvinylalcohol substitution degree and the polymer-drug weight ratios in the preparative mixture on the progesterone dissolution rate in the aqueous environment.


Assuntos
Portadores de Fármacos/química , Excipientes Farmacêuticos/química , Polietilenoglicóis/química , Álcool de Polivinil/química , Varredura Diferencial de Calorimetria , Portadores de Fármacos/síntese química , Composição de Medicamentos , Incompatibilidade de Medicamentos , Hormônios Esteroides Gonadais/química , Interações Hidrofóbicas e Hidrofílicas , Excipientes Farmacêuticos/síntese química , Polietilenoglicóis/síntese química , Polímeros , Álcool de Polivinil/síntese química , Progesterona/química , Solubilidade , Fatores de Tempo
7.
J Control Release ; 79(1-3): 173-82, 2002 Feb 19.
Artigo em Inglês | MEDLINE | ID: mdl-11853929

RESUMO

Starch-g-poly(acrylic acid) copolymers or grafted starches synthesized by 60Co irradiation or chemical modification and co-freeze-dried starch/poly(acrylic acid) mixtures were evaluated on their ex vivo bioadhesion capacity. The buccal absorption of testosterone from a bioadhesive tablet formulated with the grafted starches or starch/poly(acrylic acid) mixtures was investigated. The results were compared to a reference formulation (physical mixture of 5% Carbopol 974P and 95% Drum Dried Waxy Maize). Rice starch-based irradiated grafted starches showed the best bioadhesion results. Partial neutralization of the acrylic acid with Ca(2+) ions resulted in significantly higher bioadhesion values compared to the reference. Ca(2+) and Mg(2+) partially neutralized maltodextrin-based irradiated grafted starches showed significantly higher bioadhesion values compared to the reference formulation. The chemically modified grafted starches showed significantly higher adhesion force values than for the reference tablet. None of the co-freeze-dried starch/poly(acrylic acid) mixtures showed significantly higher bioadhesion results than the reference (Bonferroni test, P<0.05). A chemically modified grafted starch could sustain the 3 ng/ml plasma testosterone target concentration during +/- 8 h (T(>3 ng/ml)). By lyophilization of a partially neutralized irradiated grafted starch, the in vivo adhesion time (22.0 +/- 7.2 h) and the T(>3 ng/ml) (13.5 +/- 1.3 h) could be increased. The absolute bioavailability of the lyophilized formulation approached the reference formulation. Some of the grafted starches showed to be promising buccal bioadhesive drug carriers for systemic delivery.


Assuntos
Adesivos/química , Amido/análogos & derivados , Amido/química , Testosterona/farmacocinética , Adesivos/farmacocinética , Animais , Disponibilidade Biológica , Química Farmacêutica , Cães , Portadores de Fármacos/química , Portadores de Fármacos/farmacocinética , Avaliação Pré-Clínica de Medicamentos , Hormônios Esteroides Gonadais/química , Hormônios Esteroides Gonadais/farmacocinética , Masculino , Amido/farmacocinética , Testosterona/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA